A Gated Community for Oncology Nurses and
Cancer Care Teams | More Info
Breast   |   Prostate   |   Lung   |   Hematology   |   Skin   |   Gastrointestinal   |   Genitourinary   |   Head / Neck   |   Brain   |   Gynecological   |   Sarcoma   |   Thyroid
Career  |  Exercise  |  Nutrition  |  Recipes  |  Survivorship  |  Symptom Management  |  Emergencies  |  Side Effects  |  Pediatrics  |  Complementary Therapies
Blog Roll
Julianna Paradisi

Interpreting Cairns: Advanced Directives & DNRs

View Comments: Newest First | Oldest First | Threaded View
More Blogs from...
Julianna Paradisi
Julianna Paradisi wants to know what you do to help minimize the risk of chemotherapy and radiation exposure.
Julianna Paradisi shares some advice for nurses looking to join the field of oncology.
Julianna Paradisi explains about how we can maintain those healthy resolutions -- even during the cold winter season.
Oncology infusion nurse Julianna Paradisi explains how the anti-vaccine trend may impact neutropenic cancer patients.
Oncology infusion nurse Julianna Paradisi explains that not all chemotherapy treatment is used for cancer.
Webinar Series
Tuesday, October 29, 2013 12:00 PM EDT

Presented by Ellen T. Matloff, MS, CGC , this webinar will highlight:

  • How to determine which patients require genetic counseling
  • How to help prepare your patients for the genetic counseling process
  • Testing options that are now available
  • How you can utilize this data in managing your patients and their family members

Participants will also be able to ask questions during a live question and answer period with speaker Ellen T. Matloff, MS, CGC .

Wednesday, August 28, 2013 12:00 PM EDT
Wednesday, June 26, 2013 12:00 PM EDT
Wednesday, April 10, 2013 12:00 PM EDT
Have a question or topic but don't want to write a blog? Post it on our readerboards and get feedback from the community!
stopcancer on Community-based Cancer Support Services Centers
HumptyDumpty on Family and chemotherapy
melissann512 on Oncology Nurse Navigator
FDA Approves Onivyde for Advanced Pancreatic Cancer
Marijke Vroomen Durning, RN,
10/27/2015  3
On October 22, 2015, the US Food and Drug Administration (FDA) approved Onivyde (irinotecan liposome injection, Merrimack Pharmaceuticals, Inc.), in combination with fluorouracil ...
Like Us on Facebook
on Twitter
TheONC Twitter Feed